RSS Search

 News  Feeds  Images  Tags  Search Shortcuts

Feedsfarm.com > Feeds > bizjournals.com Health Care:Pharmaceuticals headlines > Archive

bizjournals.com Health Care:Pharmaceuticals headlines News Archive

Health Care:Pharmaceuticals headlines from the week of November 13, 2006

http://www.bizjournals.com/rss/feed/vertical_subtopic/36

Page: 1 of 11 bizjournals.com Health Care:Pharmaceuticals headlines

  1. New cancer center opens in Kissimmee
  2. BioVeris licenses strep vaccine
  3. GenVec claims encouraging results from HIV vaccine study
  4. Panacos asks regulator to OK stock sales
  5. Albany drug discovery company to continue supplying GE unit with materials
  6. Alliance brings more tests to Ivax Diagnostics products
  7. Immunetrics, Lilly plan technology collaboration
  8. Caremark to pay $137M in settlement
  9. Genaera gets intellectual property patent
  10. Novavax introduces new vice president
  11. FDA panel approves Nektar's inhaled insulin
  12. Introgen product offers additional therapeutic effect
  13. Discovery Labs testing breathing treatment for premature infants
  14. Tyco sells Radionics unit for $80M
  15. Biotech hat trick
  16. HIV drug created at UNC generates buzz
  17. Injunction doesn't end Bio-Rad patent battle
  18. Cephalon technology now used in new formulation of Clarinex
  19. Mayo trials begin for Myeloma treatment
  20. Bayer applies to sell kidney cancer drug in Europe
  21. Grant to fund leukemia study at Children's
  22. Hybridon drops its name, emerges as Idera Pharmaceuticals
  23. Prasco to market generic Allegra
  24. SFBC exec sells 21% of directly held stock
  25. PRA to manage Phase III lung cancer trial
  26. FDA to expedite review of kidney cancer drug
  27. Valeant sells Ohio facility
  28. FoxHollow inks deal with Merck
  29. Epix hires former TKT chief as interim CEO
  30. Genaera completes stock sale
  31. Geron expects $72 million from new stock offering
  32. Stem cell company sold
  33. Sigma-Aldrich unit gets patent
  34. CVS completes pharmacy operations at Astrodome
  35. Inverness to pay $52.5M for Thermo BioStar
  36. KV Pharma licenses products in Scandinavia
  37. Icoria sold for $12.5M
  38. Monsanto inks licensing agreements with two firms
  39. Genzyme launches program for area osteoarthritis patients
  40. Zen-Bio wins $961,578 NIH grant
  41. INC Research names Avos CEO to board
  42. UC to study alternative stroke treatments
  43. Radiant Medical begins human tests of heart treatment
  44. Regulators place hold on ViaCell clinical trial
  45. Cellerant Therapeutics gets $9M in new funding
  46. Sigma-Aldrich forms pact with MedAssets
  47. Novavax sells some product lines
  48. AstraZeneca seeks approval for Symbicort
  49. Nanotech firm prepares for funding, human tests
  50. Diabetes device lures $5M in venture funds
  51. Millennium, facing profit goal, weighs cost cutting
  52. Shedding workers
  53. Stroke drug licensed to Japanese firm
  54. Albany Molecular files suit to halt generic versions of its moneymaker
  55. Databases tapped to improve pharmaceutical marketing
  56. UC recruits team of four for Parkinson's research
  57. Building a better stem cell
  58. McKesson channels drug distribution through Conroe
  59. Clinical trials offer rewards, risks for docs
  60. Firm digests the advantage of its OatVantage additive
  61. New drug to save preemies
  62. Amicus Therapeutics banks $55M to forward its drug research
  63. Ex-HHS chief has ideas on how to get people to get healthy
  64. Biotech industry cries foul over NYSE postponing LSR's listing
  65. Leading Adherex into cancer battle
  66. Specialty pharmas hunt for treatments to tweak, market
  67. Early-stage drug program facing skeptics
  68. Duke among those enlisted for federal program
  69. Avalon IPO moving along
  70. Merck extends hurricane relief
  71. Cornerstone BioPharma hires McEwan as CFO
  72. Questcor names new CFO
  73. Residents sue Mounds View to block Medtronic deal
  74. Ev3 to stop developing device
  75. Florida to award Geo contract for new prison
  76. FDA ends Endo licensing plan
  77. Altus Pharma moves to midstage trials with key compound
  78. Third Wave draws patent lawsuit; wins injunction against rival
  79. Salud! Tampa has something to sneeze at
  80. Quintiles closes on $125M sale
  81. FDA approves new Guidant defibrillator
  82. Phoenix Data continues on the rise
  83. For some, feeling better outweighs treatment risks
  84. Employers brace for challenges in pharmacy cost management
  85. Questions, new test could help determine HIV status
  86. Ventaira taps product development chief
  87. FDA OKs Lannett's endometriosis treatment
  88. Divergence gets $296,000 SBIR grant
  89. Merck to replace prescriptions for hurricane victims
  90. Vertex stock at recent high on positive trial data
  91. CombinatoRx deal with Angiotech could bring $500M
  92. KRG sells CCS Medical
  93. GenVec gets nearly $10M for HIV work
  94. MIT's Schrock shares chemistry Nobel
  95. CSC unit awarded infectious disease contract
  96. Epix gets EU green light to sell imaging compound
  97. UT gets $3.5M for drug development institute
  98. Ivax: Not negotiating on Lexapro
  99. Soliant acquires Bilingual Therapies
  100. Seaflower Ventures brings in new principal